Furazolidone

This classification denotes an anti-infective agent with the molecular formula C8H7N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5J9CPU3RE0, chemically known as 2-furanmethanimine, 5-nitro-n-(2-oxo-3-oxazolidinyl)- but more generally known as furazolidone, which bears US NIH Compound Identifier 3435. European Medicines Agency schedules Furazolidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07834MIG. The term FURAZOLIDONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules furazolidone in its Anatomical Therapeutic Chemical (ATC) Classification. FURAZOLIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule furazolidone under HS 29349920 and SITC 51579. As of Q4 2014, FURAZOLIDONE remains US FDA's Preferred Term for this commodity. Furazolidone bears US NLM identifiers UMLS ID C0016855 and NCI Concept Code C65783. SMILES: O1CCN(/N=C/C2OC([N](=O)O)CC2)C1=O.